medline.ch Respirationstrakt Interstitielle Pneumopathien

	Inflammatory mediators in various molecular pathways involved in the development of pulmonary fibrosis. Int Immunopharmacol Fathimath Muneesa M, Shaikh SB, Jeena TM, Bhandary YP. PMID: 33857801 [PubMed - as supplied by publisher]
	Correction to: Risk of progression of idiopathic pulmonary fibrosis to connective tissue disease: a long-term observational study in 527 patients. Clin Rheumatol Ghang B, Nam SH, Lee J, Lim DH, Ahn SM, Hong JS, Kim YG, Yoo B, Kim J, Lee CK. PMID: 33856625 [PubMed - as supplied by publisher]
	Delphi Consensus Recommendations on Management of Dosing, Adverse Events, and Comorbidities in the Treatment of Idiopathic Pulmonary Fibrosis with Nintedanib. Clin Med Insights Circ Respir Pulm Med Rahaghi F, Belperio JA, Fitzgerald J, Gulati M, Hallowell R, Highland KB, Huie TJ, Kim HJ, Kolb M, Lasky JA, Southern BD, Swigris JJ, de Andrade JA. PMID: 33854398 [PubMed]
	Glucagon-like peptide-1 (GLP-1) improved diabetic lung fibrosis via AMPK and microRNA-27a (miR-27a). Ann Transl Med Liu J, Li X, Lu S, Zheng X, Zhang X, Zhao W. PMID: 33850889 [PubMed]
	Bone marrow-derived mesenchymal stem cells attenuate silica-induced pulmonary fibrosis by inhibiting apoptosis and pyroptosis but not autophagy in rats. Ecotoxicol Environ Saf Zhao Q, Hao C, Wei J, Huang R, Li C, Yao W. PMID: 33848736 [PubMed - as supplied by publisher]
	Effectiveness of Targeted Interventions on Treatment of Infants With Bronchiolitis: A Randomized Clinical Trial. JAMA Pediatr Haskell L, Tavender EJ, Wilson CL, O'Brien S, Babl FE, Borland ML, Cotterell E, Schembri R, Orsini F, Sheridan N, Johnson DW, Oakley E, Dalziel SR, PREDICT Network.. PMID: 33843971 [PubMed - as supplied by publisher]
	Action plans in idiopathic pulmonary fibrosis: a qualitative study-'I do what I can do'. BMJ Support Palliat Care Kalluri M, Younus S, Archibald N, Richman-Eisenstat J, Pooler C. PMID: 33832967 [PubMed - as supplied by publisher]
	Prognostic role of Krebs von den Lungen-6 (KL-6) measurement in idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Clin Chem Lab Med Aloisio E, Braga F, Puricelli C, Panteghini M. PMID: 33831978 [PubMed - as supplied by publisher]
	Effect of combined pulmonary fibrosis and emphysema on patients with connective tissue diseases and systemic sclerosis: a systematic review and meta-analysis. Arthritis Res Ther Koo BS, Park KY, Lee HJ, Kim HJ, Ahn HS, Yim SY, Jun JB. PMID: 33823923 [PubMed - in process]
	The function of non-coding RNAs in idiopathic pulmonary fibrosis. Open Med (Wars) Zhang H, Song M, Guo J, Ma J, Qiu M, Yang Z. PMID: 33817326 [PubMed]
	Novel QSAR Models for Molecular Initiating Event Modeling in Two Intersecting Adverse Outcome Pathways Based Pulmonary Fibrosis Prediction for Biocidal Mixtures. Toxics Seo M, Chae CH, Lee Y, Kim HR, Kim J. PMID: 33809804 [PubMed]
	Immune Stroma in Lung Cancer and Idiopathic Pulmonary Fibrosis: A Common Biologic Landscape? Int J Mol Sci Lettieri S, Oggionni T, Lancia A, Bortolotto C, Stella GM. PMID: 33809111 [PubMed - in process]
	Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be. J Clin Med Goos T, De Sadeleer LJ, Yserbyt J, Verleden GM, Vermant M, Verleden SE, Wuyts WA. PMID: 33807034 [PubMed]
	Post COVID-19 Organizing Pneumonia: The Right Time to Interfere. Medicina (Kaunas) Bieksiene K, Zaveckiene J, Malakauskas K, Vaguliene N, Zemaitis M, Miliauskas S. PMID: 33803690 [PubMed - indexed for MEDLINE]
	Prevalence, predicting factors and impact of internet use by patients with idiopathic pulmonary fibrosis: A cross-sectional observational study. Respir Med Res Le Garrec M, Rousseau C, Thépault F, Kerjouan M, Salé A, Jouneau S. PMID: 33799120 [PubMed - as supplied by publisher]
	Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial. Lancet Respir Med Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, Bonnet R, Grohe C, Held M, Wilkens H, Hammerl P, Koschel D, Blaas S, Wirtz H, Ficker JH, Neumeister W, Schönfeld N, Claussen M, Kneidinger N, Frankenberger M, Hummler S, Kahn N, Tello S, Freise J, Welte T, Neuser P, Günther A, RELIEF investigators.. PMID: 33798455 [PubMed - as supplied by publisher]
	Effect of Fluorofenidone Against Paraquat-Induced Pulmonary Fibrosis Based on Metabolomics and Network Pharmacology. Med Sci Monit Jiang F, Wang T, Li S, Jiang Y, Chen Z, Liu W. PMID: 33790218 [PubMed - in process]
	Autoantibody Positivity Is a Risk Factor for Chemotherapy-induced Exacerbation of Interstitial Pneumonia in Lung Cancer. Anticancer Res Ito N, Masuda T, Nakashima T, Nakao S, Yamaguchi K, Sakamoto S, Horimasu Y, Miyamoto S, Iwamoto H, Fujitaka K, Hamada H, Hattori N. PMID: 33788742 [PubMed - indexed for MEDLINE]
	Sjogren's Syndrome and Pulmonary Disease. Adv Exp Med Biol Peredo RA, Beegle S. PMID: 33788195 [PubMed - indexed for MEDLINE]
	Systemic Sclerosis and Pulmonary Disease. Adv Exp Med Biol Ngo K. PMID: 33788193 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 27258

Seite 1 von 1363



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung